Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Title
Intervention Indication Therapeutic Area Year Actions
Abemaciclib with fulvestrant for HR+/HER2- locally advanced or metastatic breast cancer after CDK4/6 inhibitor and endocrine therapy Abemaciclib (LY2835219; Verzenio; CC-115) , Fulvestrant (Faslodex) Breast cancer Breast Cancer 2024 View  |  Download
Abemaciclib with abiraterone acetate and prednisone for metastatic castration-resistant prostate cancer Abemaciclib (LY2835219; Verzenio; CC-115) , Abiraterone acetate (Zytiga; Yonsa) , Prednisone (Decadron; Lodotra) Prostate cancer Male Reproductive Cancer 2022 View  |  Download
Abemaciclib in combination with fulvestrant for advanced or metastatic breast cancer after prior endocrine therapy Abemaciclib (LY2835219; Verzenio; CC-115) , Fulvestrant (Faslodex) Breast cancer Breast Cancer 2017 View  |  Download
Abemaciclib for early breast cancer – adjuvant treatment Abemaciclib (LY2835219; Verzenio; CC-115) Breast cancer Breast Cancer 2020 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications